Biosensors & POCT– category –
-
Biosensors & POCT
ACS Applied Nano Materials Reviews Single-Atom Nanozymes: Drastically Improving Sensitivity and Specificity for Biomolecule and Pollutant Detection
ACS Applied Nano Materials USA Overview Single-atom nanozymes (SAzymes) significantly reduce detection limits (LOD) and improve detection sensitivity and specificity due to their highly efficient substrate catalysis. These properties pos... -
Biosensors & POCT
MDPI: Nanoparticle-Based Biosensors Redefine Biomedical Diagnostics and Environmental Monitoring, Enhancing Pathogenic Nucleic Acid Detection Sensitivity
MDPI Switzerland Overview According to an editorial in MDPI, nanoparticle-based biosensors are redefining the future of biomedical diagnostics and environmental monitoring. Diagnostic platforms leveraging nanoparticles have significantly... -
Biosensors & POCT
ACS Publications Unveils Multimodal Cell-Free Biosensing Platform for Highly Sensitive Detection of Lethal Mushroom Toxin α-Amanitin
ACS Publications USA Overview This research developed a transcription-based multimodal cell-free biosensing platform for highly sensitive detection of α-amanitin, a lethal mushroom toxin. The platform converts α-amanitin-dependent RNA po... -
Biosensors & POCT
Smartwatches Revolutionize Blood Sugar Management: Dexcom G7 and FreeStyle Libre Enhance Apple Watch Integration, Expanding AI-Driven Ecosystem
TechRepublic USA Overview Smartwatches hold the potential to transform glucose tracking, but current advancements rely on the integration of continuous glucose monitoring (CGM), artificial intelligence (AI), and regulated healthcare tech... -
Biosensors & POCT
China’s POMDOCTOR Pivots to AI-Driven Predictive Healthcare Platform, Integrating Wearables & Data for Enhanced Chronic Disease Management
Stock Titan China Overview China-based digital healthcare company POMDOCTOR announced a strategic pivot to an AI-driven predictive healthcare platform. The company plans to integrate wearable devices, artificial intelligence, physician r... -
Biosensors & POCT
July 2026 Digital Health Trends: AI Wearable Patch Hits 99.6% Arrhythmia Detection, Clair Health Secures $11.6M for Women’s Health Wearable
Digital Health Trends (Openloop Health blog) USA Overview June 2026 marked significant advancements in digital health. An AI wearable patch achieved 99.6% accuracy in detecting life-threatening arrhythmias, while Midjourney unveiled an u... -
Biosensors & POCT
RSC Publishing: Machine Learning-Augmented Lateral Flow Assays Dramatically Boost Sensitivity & Quantification in Infectious Disease POCT Diagnostics
Lab on a Chip (RSC Publishing) UK Overview Lateral Flow Assays (LFAs) are widely used as Point-of-Care (PoC) diagnostic platforms for infectious diseases due to their rapid operation, low cost, and user-friendly design. However, conventi... -
Biosensors & POCT
MEDICA Highlights POCT’s Critical Role in Emergency Departments: Rapid Diagnostics Enhance Clinical Decision-Making in Time-Sensitive Situations
MEDICA Germany Overview MEDICA emphasized that Point-of-Care Testing (POCT) in emergency departments significantly supports clinical decision-making in time-constrained situations by providing rapid diagnostic data. POCT delivers critica... -
Biosensors & POCT
Continuous Lactate Monitoring: The Next Breakthrough After CGM, Driven by Wearable Sensors and AI
After CGM (Diabetes in Control) USA Overview While Continuous Glucose Monitoring (CGM) revolutionized diabetes management, Continuous Lactate Monitoring (CLM) is now discussed as the next significant advance in metabolic monitoring. Lact... -
Biosensors & POCT
MDPI: Nanomaterial & AI-Enhanced Biosensors Modernize Asthma Diagnostics, Enabling Low-Concentration Detection of Salivary IL-8 and Other Biomarkers
MDPI Switzerland Overview Biosensors enhanced by nanomaterials and artificial intelligence are driving the modernization of asthma diagnostics. Optical biosensors are gaining popularity due to their real-time, label-free detection capabi...